Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Book Proposal
Become an Executive Guest Editor
New Journal Proposal
Become a Section Editor
Become a Reviewer
Join Editorial Board
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 16
- Number 2
Meet Our Editorial Board Member:
,
16
(
2
):
99
Wei Wang
DOI:
10.2174/156800961602160105153729
Permissions
Order Reprints
Order Eprints
Editorial
Editorial (Thematic Issue: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy)
,
16
(
2
):
100
Masatoshi Kitagawa
DOI:
10.2174/156800961602160105154407
View Editorial
Permissions
Download Free
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response
,
16
(
2
):
101
- 109
Takayo Fukuda, Tomoko Tsuruga, Takako Kuroda, Hiroyuki Nishikawa and Tomohiko Ohta
DOI:
10.2174/1568009615666151030102427
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer
,
16
(
2
):
110
- 118
Yasumichi Inoue, Yuka Itoh, Koichi Sato, Fumihiro Kawasaki, Chihiro Sumita, Takahito Tanaka, Daisuke Morishita and Hidetoshi Hayashi
DOI:
10.2174/1568009616666151112122126
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
,
16
(
2
):
119
- 129
Kyoko Kitagawa and Masatoshi Kitagawa
DOI:
10.2174/1568009616666151112122231
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers
,
16
(
2
):
130
- 135
Kazuma Masumoto and Masatoshi Kitagawa
DOI:
10.2174/1568009616666151112122336
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
,
16
(
2
):
136
- 146
Nobumichi Ohoka, Norihito Shibata, Takayuki Hattori and Mikihiko Naito
DOI:
10.2174/1568009616666151112122502
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
,
16
(
2
):
147
- 156
Satoshi Sakai, Chiharu Miyajima, Chiharu Uchida, Yuka Itoh, Hidetoshi Hayashi and Yasumichi Inoue
DOI:
10.2174/1568009616666151112122645
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
,
16
(
2
):
157
- 174
Chiharu Uchida and Masatoshi Kitagawa
DOI:
10.2174/1568009616666151112122801
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
,
16
(
2
):
175
- 185
Erika Giordani, Federica Zoratto, Martina Strudel, Anselmo Papa, Luigi Rossi, Marina Minozzi, Davide Caruso, Eleonora Zaccarelli, Monica Verrico and Silverio Tomao
DOI:
10.2174/1568009615666150817120712
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition
,
16
(
2
):
186
- 197
Tiziana Guarnieri
DOI:
10.2174/1568009615666150827093012
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics:
5.2
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy